InfoBionic: Set to Disrupt Arrhythmia Monitoring

article image
ARTICLE SUMMARY:

Cardiac monitoring for the detection of arrhythmias such as atrial fibrillation has evolved into a fragmented and complex market with embedded inefficiencies that make monitoring cumbersome and delay diagnosis. While medical device companies to date have focused on patient-worn or implanted monitoring components, InfoBionic believes it will disrupt the market with a focus on the back-end: the Cloud-based analytics and software.

In just two weeks, InfoBionic Inc. will commercialize a new HIPAA-co mpliant, Cloud-based cardiac monitoring platform for the detection of arrhythmias such as atrial fibrillation.

×



This article is restricted to subscribers only.

Sign in to continue reading.

Questions?

We're here to help! Please contact us at: